Preterm Labor and Birth: Pathophysiology, Diagnostic Stratification, Management Strategies, and Neonatal Outcomes

1. Arslan Mazhar

2. Osmonova Gulnaz Zhenishbaevna

(1. Student, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic

2. Teacher, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic.)

Abstract

Preterm labor and preterm birth constitute the leading cause of perinatal morbidity and mortality worldwide, accounting for approximately 10 percent of all births globally. This comprehensive review synthesizes contemporary clinical literature regarding the etiology, diagnostic evaluation, therapeutic interventions, and long-term outcomes associated with preterm birth. Utilizing an exhaustive academic framework, this study examines the pathophysiological pathways that trigger premature uterine contractions and cervical remodeling, including subclinical intra-amniotic infection, inflammation, vascular disease, uterine overdistension, and hypothalamic-pituitary-adrenal axis activation. Diagnostic methodologies are systematically evaluated, emphasizing transvaginal ultrasonographic cervical length surveillance, fetal fibronectin testing, and emerging biomarkers of sterile inflammation. Therapeutic strategies are appraised with a focus on targeted mechanical and pharmacological interventions, such as micronized vaginal progesterone, cervical cerclage, acute tocolytic administration, antenatal corticosteroids for fetal lung maturation, and magnesium sulfate for neuroprotection. Outcome parameters analyze neonates across varying gestational strata, highlighting respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis, and chronic neurodevelopmental sequelae. Standardizing clinical protocols through early biomarker detection and targeted biological interventions remains the most effective avenue for reducing global preterm birth rates and mitigating long-term adverse neonatal events.

Introduction

Preterm birth, defined by the World Health Organization as live delivery occurring prior to 37 completed weeks or 259 days of gestation, represents a major challenge in modern obstetrics and neonatology. Globally, an estimated 13.4 million infants are born preterm each year, representing a substantial public health burden characterized by high rates of immediate neonatal mortality and lifelong disability. The clinical spectrum of premature birth spans multiple developmental thresholds: extremely preterm (less than 28 weeks), very preterm (28 to 31 weeks and 6 days), moderate preterm (32 to 33 weeks and 6 days), and late preterm (34 to 36 weeks and 6 days). The absolute majority of preterm births fall within the late preterm category, yet the highest disproportionate risk of severe morbidity and mortality resides within the extremely and very preterm cohorts.

The etiology of preterm birth is heterogeneous and divided into two clinical categories: spontaneous preterm birth, which accounts for roughly 70 percent of cases, and medically indicated or iatrogenic preterm birth, comprising the remaining 30 percent. Spontaneous preterm birth encompasses cases resulting from spontaneous preterm labor with intact membranes as well as those initiated by preterm prelabor rupture of membranes. Conversely, medically indicated preterm delivery is initiated by maternal or fetal compromise, such as severe preeclampsia, intrauterine growth restriction, placental abruption, or fetal distress, where the risk of continuing the pregnancy outweighs the risks associated with premature delivery.

Despite substantial advances in neonatal intensive care that have drastically improved survival rates among extremely low birth weight infants, the primary incidence of spontaneous preterm labor has demonstrated minimal decline over recent decades. This persistence stems from the multifactorial biological nature of labor initiation, which involves complex biochemical pathways, genetic predispositions, environmental stressors, and endocrine regulatory loops. Understanding spontaneous preterm birth requires viewing labor not as a single pathological event, but rather as a common terminal pathway triggered by diverse upstream pathological mechanisms.

The clinical consequences of preterm birth extend across the lifespan. In the immediate neonatal period, premature infants face critical physiological challenges due to structural and functional immaturity of vital organ systems. Respiratory distress syndrome resulting from surfactant deficiency, severe intraventricular hemorrhage due to fragile germinal matrix vasculature, necrotizing enterocolitis, and systemic neonatal sepsis represent primary threats to survival during the acute phase. In the long term, surviving infants exhibit increased risks of cerebral palsy, neurodevelopmental delays, chronic lung disease, and adult-onset metabolic disturbances.

Given the profound clinical and socioeconomic implications of premature delivery, establishing precise diagnostic frameworks and standardized therapeutic algorithms is essential. The objective of this study is to examine the contemporary landscape of preterm labor and birth using an integrated IMRAD structure, delivering a detailed analysis of disease mechanisms, diagnostic testing, therapeutic protocols, and perinatal outcomes.

Methods

To systematically evaluate the evidence base surrounding preterm labor and birth, a structured academic review methodology was implemented. Primary focus was directed toward identifying high-quality clinical studies, randomized controlled trials, systematic reviews, and consensus guidelines published across major medical literature repositories, including PubMed, MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials.

Study Inclusion Criteria

Studies evaluated within this review were required to meet defined clinical and methodological parameters. Eligible studies included prospective observational studies, double-blind randomized controlled trials, systematic reviews, and meta-analyses investigating singleton or multifetal human pregnancies between 20 and 36 completed weeks of gestation. Key focus areas were restricted to pathophysiological mechanisms, diagnostic biomarkers, cervical length screening, preventative progestogens, cerclage interventions, acute tocolysis, antenatal corticosteroid administration, magnesium sulfate neuroprotection, and long-term neonatal neurodevelopmental tracking.

Data Synthesis and Analytical Framework

Extracted data were organized according to specific analytical categories within the core subject areas. Pathophysiological data were categorized by primary molecular pathway, including inflammatory cascades, extracellular matrix digestion, endocrine signalling, and biomechanical distension. Diagnostic accuracy metrics were synthesized based on sensitivity, specificity, positive predictive value, and negative predictive value for transvaginal ultrasound cervical length measurements and biochemical assays. Clinical interventions were evaluated by calculating relative risk reductions, odds ratios, and numbers needed to treat across specific gestational age windows.

Results

Pathophysiology and Upstream Etiological Mechanisms

The transition of the human uterus from a quiescent state to an active organ of expulsion is mediated by an intricate biochemical network. Under normal physiological conditions, uterine quiescence is actively maintained throughout the majority of pregnancy by circulating progesterone, which suppresses inflammatory gene expression, inhibits myometrial gap junction formation, and downregulates contraction-associated proteins. Spontaneous preterm labor represents a pathological breakdown of this quiescent state, brought on by the premature activation of one or more distinct physiological triggers.

Subclinical intrauterine infection and inflammatory pathways represent the most clearly established causative mechanisms of early spontaneous preterm birth. Microorganisms originating from the lower genital tract ascend through the cervix into the choriodecidual space, inducing local inflammatory activation. The primary cellular response involves the activation of pattern recognition receptors, particularly Toll-like receptors, which recognize pathogen-associated molecular patterns. Activation of Toll-like receptors initiates an intracellular signaling cascade mediated by nuclear factor kappa B, leading to the rapid synthesis and release of pro-inflammatory cytokines, including interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha.

These pro-inflammatory cytokines stimulate local decidual and fetal membrane cells to produce matrix metalloproteinases, specifically MMP-1, MMP-8, and MMP-9. Matrix metalloproteinases are proteolytic enzymes that degrade collagen types I, III, and IV within the extracellular matrix of the cervix and fetal membranes. Degradation of structural collagen reduces the tensile strength of the amnion and chorion, predisposing them to preterm prelabor rupture of membranes, while simultaneously facilitating cervical softening, shortening, and dilation. Furthermore, inflammatory cytokines upregulate cyclooxygenase-2 expression within decidual and myometrial tissues, accelerating the conversion of arachidonic acid to prostaglandins, notably prostaglandin E2 and prostaglandin F2-alpha. Prostaglandins act directly on myometrial smooth muscle cells to increase intracellular calcium concentrations, while inducing structural cervical remodeling.

Sterile inflammation, occurring in the absence of detectable pathogenic microorganisms, serves as an equally potent driver of premature delivery. Danger-associated molecular patterns released from damaged, senescent, or ischemic fetoplacental tissues trigger the formation of intracellular inflammasome complexes, such as the NLRP3 inflammasome. This pathway leads to the maturation and secretion of active interleukin-1 beta, which initiates the exact same enzymatic cascade of matrix metalloproteinases and prostaglandin synthesis seen in infectious etiologies.

Maternal and fetal stress pathways represent an additional pathophysiological route to preterm labor. Maternal psychological distress, physical strain, or systemic illness activates the maternal hypothalamic-pituitary-adrenal axis, elevating circulating corticotropin-releasing hormone. Concurrently, fetal distress caused by placental insufficiency or intrauterine hypoxia stimulates the fetal hypothalamic-pituitary-adrenal axis, producing elevated levels of fetal adrenocorticotropic hormone and cortisol. Fetal cortisol stimulates placental synthesis and release of corticotropin-releasing hormone into the maternal circulation. Corticotropin-releasing hormone acts on decidual and myometrial receptors to enhance prostaglandin production and upregulate myometrial oxytocin receptor sensitivity, bypassing normal progesterone-mediated quiescence.

Physical uterine overdistension, commonly seen in multifetal gestations, polyhydramnios, or uterine structural anomalies, induces preterm labor via mechanotransduction. Passive stretching of myometrial smooth muscle fibers activates stretch-sensitive ion channels, inducing depolarizing membrane potentials and influx of extracellular calcium. Mechanical stretch directly upregulates the expression of contraction-associated proteins, including connexin-43, oxytocin receptors, and prostaglandin receptors. Connexin-43 forms low-resistance gap junctions between adjacent myometrial cells, transforming the uterus into a electrically synchronized organ capable of generating forceful, coordinated contractions.

Decidual hemorrhage and vascular disease represent a fifth major pathophysiological pathway. Disruption of maternal-fetal vascular integrity leads to microvascular thrombosis, decidual ischemia, and hemorrhage. Thrombin generated during the coagulation cascade binds to protease-activated receptors on decidual cells, inducing the release of matrix metalloproteinases and pro-inflammatory cytokines while increasing local prostaglandin synthesis.

Diagnostic Stratification and Risk Assessment

Accurate differentiation between true progressive preterm labor and benign, non-progressive uterine activity remains a clinical challenge. Up to 50 percent of women presenting with clinical signs of preterm labor require no intervention and ultimately deliver at term. Diagnostic stratification relies on combining physical examination findings, transvaginal ultrasonographic assessment of cervical length, and biochemical biomarker assays.

Digital cervical examination provides a baseline evaluation of dilation, effacement, and fetal station. However, digital examination is subject to high inter-observer variability and possesses low sensitivity for predicting preterm delivery in early labor. Consequently, transvaginal ultrasonographic measurement of cervical length has emerged as the primary imaging modality for risk stratification.

In low-risk asymptomatic singleton pregnancies evaluated between 18 and 24 weeks of gestation during routine anatomical survey, a normal cervical length measures between 35 and 45 mm. A cervical length measuring less than 25 mm is defined as a short cervix and carries an increased relative risk of spontaneous preterm birth. The risk increases exponentially as cervical length decreases: a cervix measuring less than 15 mm between 22 and 24 weeks is associated with a risk of spontaneous delivery before 32 weeks that exceeds 30 percent. In symptomatic women presenting with painful contractions between 24 and 34 weeks, a transvaginal cervical length greater than 30 mm effectively excludes impending preterm birth, demonstrating a negative predictive value exceeding 95 percent for delivery within seven days. Conversely, a cervical length of less than 15 mm in symptomatic patients indicates a high probability of delivery within one week, justifying immediate inpatient hospitalization and targeted intervention.

For symptomatic patients with an indeterminate cervical length between 15 and 30 mm, biochemical testing provides critical secondary risk stratification. Fetal fibronectin is an extracellular matrix glycoprotein localized to the maternal-fetal interface at the decidua-chorion junction. It functions as biological adhesive glue anchoring the gestational sac to the uterine wall. Prior to 20 weeks of gestation, fetal fibronectin is normally detectable in cervicovaginal secretions. Between 22 and 35 weeks, the maternal-fetal interface is fully intact, and fetal fibronectin should remain undetectable. Mechanical disruption of the choriodecidual junction caused by micro-contractions or extracellular matrix degradation releases fetal fibronectin into the cervicovaginal fluid.

A qualitative fetal fibronectin test result is defined as positive at a threshold of 50 ng/mL or greater. The clinical utility of fetal fibronectin testing resides in its negative predictive value rather than its positive predictive value. A negative fetal fibronectin result in a symptomatic patient with intact membranes provides a 97 to 99 percent probability that delivery will not occur within the subsequent 7 to 14 days. This enables clinicians to safely avoid unnecessary inpatient admissions, acute tocolysis, and corticosteroid exposure. Conversely, the positive predictive value of fetal fibronectin testing remains modest (15 to 25 percent), as false-positive results can be caused by recent digital cervical examination, sexual intercourse, transvaginal ultrasound examination, vaginal bleeding, or local cervicovaginal infection. Quantitative fetal fibronectin testing measures absolute concentrations in cervicovaginal secretions, providing finer risk stratification. Higher concentrations (greater than 200 ng/mL) correlate with a significantly increased absolute risk of delivery within 14 days.

Additional biochemical markers include phosphorylated insulin-like growth factor binding protein-1 and placental alpha microglobulin-1. Phosphorylated insulin-like growth factor binding protein-1 is synthesized by human decidual cells; tissue breakdown at the decidual-chorionic boundary causes leakage of this protein into the vagina, signaling imminent labor. Placental alpha microglobulin-1 is a protein secreted by amniotic cells that exists in high concentrations within amniotic fluid. When used to evaluate preterm prelabor rupture of membranes, placental alpha microglobulin-1 demonstrates high sensitivity and specificity, even in the presence of minor blood or semen contamination that would otherwise yield false-positive results on traditional nitrazine pH paper or fern testing.

Prevention and Acute Therapeutic Interventions

Management strategies for preterm labor are divided into primary, secondary, and tertiary interventions. Primary prevention targets broad population-level risk factors, such as smoking cessation, optimization of interpregnancy intervals, treatment of underlying maternal chronic illness, and infection screening. Secondary prevention focuses on high-risk individuals, such as those with a prior history of spontaneous preterm delivery or an incidentally identified short cervix. Tertiary management involves acute pharmacological stabilization of women in active preterm labor to optimize fetal outcomes prior to delivery.

Progestogen therapy represents the cornerstone of secondary prevention in high-risk pregnancies. Progesterone suppresses inflammatory pathways, maintains cervical integrity, downregulates oxytocin receptor expression, and stabilizes myometrial resting membrane potentials. In asymptomatic women with a singleton pregnancy and no prior history of preterm birth who demonstrate a short cervix (cervical length 25 mm or less) on second-trimester transvaginal ultrasound, daily vaginal progesterone administration (200 mg micronized progesterone capsule or 90 mg progesterone gel) significantly reduces the risk of preterm birth before 33 weeks and decreases composite neonatal morbidity and mortality.

For women with a singleton pregnancy and a documented history of prior spontaneous preterm birth, clinical strategy is tailored based on cervical length monitoring. Serial transvaginal ultrasound screening is initiated between 16 and 24 weeks of gestation. If the cervical length shortens to less than 25 mm prior to 24 weeks, surgical cervical cerclage is indicated. Cervical cerclage involves placing a synthetic suture or tape around the cervical os to reinforce the structural matrix of the cervix. Placement of a cerclage in this specific population significantly reduces the rate of recurrent preterm birth and improves neonatal survival.

In contrast, routine cerclage placement or progestogen supplementation is not recommended for unselected multifetal gestations, as clinical trials have failed to show a consistent reduction in preterm birth rates for twin or triplet pregnancies in the absence of a short cervix.

When a patient presents with established preterm labor between 24 and 34 weeks of gestation, tertiary management protocols are initiated. The primary goal of tertiary intervention is not to arrest labor indefinitely, but rather to delay delivery for 48 hours. This critical window allows for the complete administration of antenatal corticosteroids, the initiation of magnesium sulfate for neuroprotection, and the safe transfer of the mother to a tertiary care center with an appropriate neonatal intensive care unit.

Antenatal corticosteroid therapy represents the single most effective intervention for reducing neonatal morbidity and mortality in premature infants. Administration of betamethasone (two doses of 12 mg intramuscularly, 24 hours apart) or dexamethasone (four doses of 6 mg intramuscularly, 12 hours apart) between 24 and 34 weeks accelerates structural maturation of the fetal lungs. Corticosteroids stimulate type II pneumocytes to synthesize and secrete pulmonary surfactant, a complex of phospholipids and proteins that reduces alveolar surface tension and prevents end-expiratory collapse. Corticosteroid exposure also promotes structural maturation of the cerebral vasculature, significantly decreasing the incidence of intraventricular hemorrhage, necrotizing enterocolitis, and overall perinatal death. A single rescue course of corticosteroids may be considered in women who remain at high risk of delivery within 7 days, provided the initial course was administered more than 14 days prior and at less than 34 weeks gestation.

Acute tocolytic therapy is administered concurrently to suppress uterine contractions for up to 48 hours. Tocolytic agents operate through distinct pharmacological mechanisms:

First, calcium channel blockers, primarily oral nifedipine, inhibit the influx of extracellular calcium ions through L-type voltage-gated calcium channels in myometrial smooth muscle cells. The resulting decrease in intracellular calcium prevents calmodulin activation and myosin light-chain kinase phosphorylation, inducing myometrial relaxation. Nifedipine is generally preferred due to its favorable side effect profile, ease of administration, and high efficacy in delaying delivery for 48 hours compared to placebos.

Second, cyclooxygenase inhibitors, primarily indomethacin, block the enzymatic conversion of arachidonic acid to prostaglandins. Indomethacin is an effective tocolytic, particularly in gestations under 32 weeks. However, its use is restricted to a maximum treatment duration of 48 hours due to fetal risks. Maternal indomethacin crosses the placenta and can cause premature constriction or closure of the fetal ductus arteriosus, as well as oligohydramnios secondary to decreased fetal renal blood flow and urinary output.

Third, oxytocin receptor antagonists, such as atosiban, competitively block oxytocin receptors in the myometrium and decidua, inhibiting oxytocin-stimulated calcium release. Atosiban exhibits high uterine specificity with low maternal systemic side effects, although its availability varies geographically.

Fourth, beta-adrenergic receptor agonists, such as terbutaline, stimulate intracellular adenylate cyclase, elevating cyclic adenosine monophosphate levels and sequestering intracellular calcium. While effective at acutely inhibiting contractions, beta-agonists are associated with maternal cardiovascular side effects, including tachycardia, pulmonary edema, myocardial ischemia, and hyperglycemia, which limit their long-term clinical utility.

Magnesium sulfate administration is indicated for fetal neuroprotection in women facing imminent preterm birth before 32 weeks of gestation. Magnesium ions act as non-competitive antagonists at the N-methyl-D-aspartate receptor in the central nervous system, blocking excessive calcium influx during periods of fetal hypoxia or ischemia. Magnesium also stabilizes cerebral hemodynamics and exerts anti-inflammatory effects on vulnerable neural tissue. Clinical trials demonstrate that antenatal magnesium sulfate infusion reduces the relative risk of cerebral palsy and gross motor dysfunction in surviving infants without increasing overall perinatal mortality.

Finally, intrapartum antibiotic prophylaxis is initiated for the prevention of early-onset neonatal Group B Streptococcus infection in women presenting with active preterm labor. Intravenous penicillin G or ampicillin is administered until delivery, unless a recent cervicovaginal Group B Streptococcus screening culture obtained within the preceding five weeks yields a negative result.

Neonatal Outcomes and Morbidity Profiles

The gestational age at delivery remains the single most important determinant of immediate survival and long-term developmental outcomes for premature infants. Physiological immaturity across multiple organ systems creates vulnerabilities that require immediate intervention upon delivery.

Surfactant deficiency in the premature pulmonary system leads to widespread micro-atelectasis, ventilation-perfusion mismatch, systemic hypoxia, and hypercapnia. The resulting mechanical stress and oxidative injury damage the alveolar epithelium, causing an exudation of plasma proteins that form hyaline membranes along the terminal airways. Surfactant replacement therapy administered via endotracheal intubation, combined with non-invasive positive pressure ventilation, has transformed the clinical course of respiratory distress syndrome. However, prolonged exposure to mechanical ventilation and high oxygen concentrations can cause chronic inflammation and arrest alveolar development, resulting in bronchopulmonary dysplasia or chronic lung disease of prematurity.

In premature infants under 32 weeks, the cerebral vasculature contains a fragile structure known as the germinal matrix. The germinal matrix is a highly vascularized subependymal region rich in delicate, thin-walled capillaries lacking structural basement membrane support. Fluctuations in systemic blood pressure, cerebral blood flow, or venous pressure can rupture these delicate vessels, causing intraventricular hemorrhage. Intraventricular hemorrhage is graded on a scale from I to IV based on Papile's classification: Grade I reflects hemorrhage restricted to the germinal matrix; Grade II involves intraventricular extension without ventricular dilation; Grade III features intraventricular hemorrhage with acute ventricular dilation; and Grade IV involves severe parenchymal hemorrhagic infarction. Grades III and IV hemorrhage carry high risks of post-hemorrhagic hydrocephalus, motor deficits, and cognitive impairment. Ischemic injury to the white matter surrounding the lateral ventricles can also lead to periventricular leukomalacia, the primary pathological substrate for spastic diplegic cerebral palsy.

The gastrointestinal tract of the preterm infant is susceptible to necrotizing enterocolitis, a devastating disease characterized by intestinal mucosal necrosis, systemic inflammation, and bacterial translocation. The pathogenesis of necrotizing enterocolitis involves a combination of premature intestinal tissue, abnormal bacterial colonization, hyperosmolar enteral feeds, and intestinal ischemia-reperfusion injury. Bacterial invasion into the damaged intestinal wall produces intramural gas (pneumatosis intestinalis), which can progress to full-thickness bowel perforation, peritonitis, abdominal compartment syndrome, and septic shock.

Sepsis represents another primary threat to the premature infant. Deficiencies in both innate and adaptive immunity, combined with thin epidermal barriers and the frequent need for invasive lines, make preterm infants vulnerable to early-onset and late-onset sepsis. Common bacterial pathogens include Group B Streptococcus, Escherichia coli, Coagulase-negative Staphylococci, and Klebsiella pneumoniae. Systemic infection triggers systemic inflammatory responses that exacerbate pulmonary, cardiovascular, and neurological injuries.

Long-term epidemiological tracking of preterm cohorts reveals a continuum of neurodevelopmental outcomes that correlate directly with gestational age at birth. While extremely preterm infants face significant risks of severe motor impairments, sensory deficits, and intellectual disability, late preterm infants also show higher rates of subtle cognitive deficits, executive dysfunction, attention-deficit/hyperactivity disorder, and academic underperformance compared to full-term peers.

Discussion

The management of preterm labor and birth requires balancing diagnostic precision, preventative protocols, and acute tertiary therapies. Despite decades of clinical research, spontaneous preterm labor remains a challenging clinical entity due to its complex, overlapping physiological mechanisms. Recognizing that preterm labor is not a single disease state, but rather a unified clinical pathway resulting from multiple upstream causes—such as infection, sterile inflammation, uterine distension, and endocrine disruption—is crucial for refining therapeutic strategies.

Diagnostic pathways centered on transvaginal ultrasound cervical length screening and cervicovaginal biomarkers have advanced our ability to stratify risk in both asymptomatic and symptomatic patients. By identifying women who are at low risk for delivery within 7 to 14 days, clinicians can safely avoid unnecessary hospitalizations, acute tocolysis, and corticosteroid exposures, preserving healthcare resources for true clinical emergencies.

In terms of prevention and intervention, evidence supports the targeted use of vaginal progesterone for women with an asymptomatic short cervix, as well as cervical cerclage for those with a history of spontaneous preterm birth who develop cervical shortening. When acute labor occurs, tertiary interventions—such as antenatal corticosteroids, acute tocolysis for transfer and steroid completion, magnesium sulfate for neuroprotection, and intrapartum Group B Streptococcus prophylaxis—remain essential for reducing immediate neonatal morbidity and long-term neurological complications.

Ultimately, improving outcomes in premature labor requires a comprehensive approach that connects early risk detection, evidence-based obstetrical management, and specialized neonatal care. Future research focused on identifying precise biological pathways and diagnostic markers will be vital for developing targeted therapies to further lower preterm birth rates and mitigate their impact on infant health.

Conclusion

Preterm labor and birth remain a major challenge in modern maternal-fetal medicine, representing a leading cause of neonatal mortality and long-term neurodevelopmental morbidity. Spontaneous preterm labor is a complex syndrome triggered by diverse biological pathways, including infection, inflammation, uterine overdistension, and stress-induced endocrine activation. Modern diagnostic frameworks combining transvaginal cervical length screening with biochemical marker testing allow for accurate risk stratification, enabling targeted preventative care while preventing unnecessary interventions in low-risk patients.

Evidence-based interventions—such as prophylactic progestogens for women with a short cervix, cerclage placement for those with prior preterm deliveries, antenatal corticosteroids for lung maturation, magnesium sulfate for neuroprotection, and intrapartum antibiotic prophylaxis—have improved neonatal survival and reduced major complications. Continued translational research into the inflammatory and physiological mechanisms of labor is essential to refine predictive tools and advance preventative therapies, with the ultimate goal of reducing the global burden of preterm birth.

References

·  Goldenberg, R. L., Culhane, J. F., Iams, J. D., & Romero, R. (2008). Epidemiology and causes of preterm birth. The Lancet, 371(9606), 75–84. https://doi.org/10.1016/S0140-6736(08)60074-4

·  Romero, R., Dey, S. K., & Fisher, S. J. (2014). Preterm labor: One syndrome, many causes. Science, 345(6198), 760–765. https://doi.org/10.1126/science.1251816

·  Lawn, J. E., Blencowe, H., Oza, S., You, D., Lee, A. C., Waiswa, P., Lalli, M., Bhutta, Z., Barros, A. J., Wardlaw, T., & Cousens, S. (2014). Every Newborn: Progress, priorities, and potential beyond survival. The Lancet, 384(9938), 189–205. https://doi.org/10.1016/S0140-6736(14)60496-7

·  American College of Obstetricians and Gynecologists. (2021). Prediction and prevention of spontaneous preterm birth: ACOG Practice Bulletin, Number 234. Obstetrics & Gynecology, 138(2), e65–e90. https://doi.org/10.1097/AOG.0000000000004479

·  Society for Maternal-Fetal Medicine. (2017). The role of activity restriction in obstetric management. American Journal of Obstetrics & Gynecology, 217(2), B2–B5. https://doi.org/10.1016/j.ajog.2017.04.032

·  Vogel, J. P., Oladapo, O. T., Pileggi-Castro, C., Adejuyigbe, E. A., Althabe, F., Ariff, S., Ayede, A. I., Baqui, A. H., Costello, A., Ezati, E., & Gulmezoglu, A. M. (2017). Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: The WHO ACTION-1 randomized trial. The Lancet Global Health, 5(11), e1062–e1063. https://doi.org/10.1016/S2214-109X(17)30348-7

·  Conde-Agudelo, A., & Romero, R. (2018). Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: A meta-analysis of individual patient data. American Journal of Obstetrics & Gynecology, 218(2), 161–180. https://doi.org/10.1016/j.ajog.2017.11.576

·  Berghella, V., Ciardulli, A., Rust, O. A., To, M. S., Otsuki, K., Althuisius, S., Nicolaides, K. H., Roman, A., & Saccone, G. (2017). Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: Systematic review and meta-analysis of randomized controlled trials. Ultrasound in Obstetrics & Gynecology, 50(5), 569–577. https://doi.org/10.1002/uog.17457

·  Rouse, D. J., Hirtz, D. G., Thom, E., Varner, M. W., Spong, C. Y., Mercer, B. M., Iams, J. D., Wapner, R. J., Sorokin, Y., Alexander, J. M., & Harper, M. (2008). A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. New England Journal of Medicine, 359(9), 895–905. https://doi.org/10.1056/NEJMoa0801187

·  Saigal, S., & Doyle, L. W. (2008). An overview of mortality and sequelae of preterm birth from infancy to adulthood. The Lancet, 371(9608), 261–269. https://doi.org/10.1016/S0140-6736(08)60136-1

·  Khandre, V., Potdar, J., & Keerti, A. (2022). Preterm birth: An overview. Cureus, 14(12), e33006. https://doi.org/10.7759/cureus.33006

·  Slattery, M. M., & Morrison, J. J. (2002). Preterm delivery. The Lancet, 360(9344), 1489–1497. https://doi.org/10.1016/S0140-6736(02)11476-0

·  Mercer, B. M., Goldenberg, R. L., Meis, P. J., Moawad, A. H., Shellhaas, C., Das, A., Menard, M. K., Sorokin, Y., Johnson, F., & Miodovnik, M. (2000). The Preterm Prediction Study: Prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. American Journal of Obstetrics & Gynecology, 183(3), 738–745. https://doi.org/10.1067/mob.2000.106766

·  Vogel, J. P., Ramson, J., Darmstadt, G. L., Qureshi, Z. P., Chou, D., Bahl, R., & Oladapo, O. T. (2022). Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes. The Lancet Global Health, 10(12), e1707–e1708. https://doi.org/10.1016/S2214-109X(22)00434-X

·  Putora, K., Hornung, R., Kinkel, J., Fischer, T., & Putora, P. M. (2022). Progesterone, cervical cerclage or cervical pessary to prevent preterm birth: A decision-making analysis of international guidelines. BMC Pregnancy and Childbirth, 22(1), 355. https://doi.org/10.1186/s12884-022-04584-4